Persica Pharmaceuticals will advance its antibiotic-based drug to registrational studies after a Phase Ib study found that the therapy alleviated lower back pain in patients. The UK-based biotech ...
Persica is looking ahead to registrational trials after its antibiotic therapy met the primary endpoint in a Phase Ib trial. Image credit: Shutterstock / New Africa. Persica Pharmaceuticals will ...
Become a part of one of the friendliest photo sharing communities online. Share your photos to show-off, improve and discuss your photography, as well as get free critique on your photography.
Persica Pharmaceuticals said it has promising Phase 1b results that support its approach of using a two-dose antibiotic to treat a subset of patients with … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback